ResearcherKyushu UniversityActive in the last 2 years
Yoshinao Oda
Matched on ORCID iD 0000-0003-3546-2128; OpenAlex author ID A5101685584, A5111799637. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 31
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 6
- Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-025-03633-4↗
- Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. Co-author DOI 10.1007/s00432-025-06095-z↗
- Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. Co-author DOI 10.1007/s00535-024-02103-0↗
- Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in… Co-author DOI 10.1097/sla.0000000000003060↗
- Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL. Co-author DOI 10.3892/ijo.2016.3389↗
- Follicular pancreatitis, report of a case clinically mimicking pancreatic cancer and literature review. Last author DOI 10.1016/j.prp.2013.09.005↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Katsuhito Teramatsu · 2 shared papers, 2024–2026 · strength 0.41
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Masatoshi Murakami · 2 shared papers, 2024–2026 · strength 0.41
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Kazuhide Matsumoto · 2 shared papers, 2024–2026 · strength 0.41
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Akihisa Ohno · 2 shared papers, 2024–2026 · strength 0.41
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Nao Fujimori · 2 shared papers, 2024–2026 · strength 0.41
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Yoshihiro Ogawa · 2 shared papers, 2024–2026 · strength 0.41
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Kohei Nakata · 2 shared papers, 2024–2025 · strength 0.38
- Paper Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. DOI 10.1007/s00432-025-06095-z↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Kenoki Ohuchida · 2 shared papers, 2016–2025 · strength 0.26
- Chika Iwamoto · 1 shared paper, 2025 · strength 0.21
- Chikanori Tsutsumi · 1 shared paper, 2025 · strength 0.21
- Toshiya Abe · 1 shared paper, 2025 · strength 0.21
- Masafumi Nakamura · 1 shared paper, 2025 · strength 0.21
- Noboru Ideno · 1 shared paper, 2025 · strength 0.21
- Koki Oyama · 1 shared paper, 2025 · strength 0.21
- Naoki Ikenaga · 1 shared paper, 2025 · strength 0.21
- Tomohiko Shinkawa · 1 shared paper, 2025 · strength 0.21
- Yuki Mochida · 1 shared paper, 2025 · strength 0.21
- Takao Ohtsuka · 3 shared papers, 2014–2020 · strength 0.19
- Paper Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Fa… DOI 10.1097/sla.0000000000003060↗
- Paper Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL. DOI 10.3892/ijo.2016.3389↗
- Paper Follicular pancreatitis, report of a case clinically mimicking pancreatic cancer and literature review. DOI 10.1016/j.prp.2013.09.005↗
- Masafumi Nakamura · 1 shared paper, 2024 · strength 0.17
- Yoshinao Oda · 2 shared papers, 2016–2020 · strength 0.15
- Paper Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Fa… DOI 10.1097/sla.0000000000003060↗
- Paper Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL. DOI 10.3892/ijo.2016.3389↗
- Masafumi Nakamura · 2 shared papers, 2016–2020 · strength 0.15
- Paper Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Fa… DOI 10.1097/sla.0000000000003060↗
- Paper Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL. DOI 10.3892/ijo.2016.3389↗
- Yoshihiro Miyasaka · 2 shared papers, 2016–2020 · strength 0.15
- Paper Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Fa… DOI 10.1097/sla.0000000000003060↗
- Paper Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL. DOI 10.3892/ijo.2016.3389↗
- Ryota Matsuda · 1 shared paper, 2020 · strength 0.10
- Kiyoshi Saeki · 1 shared paper, 2020 · strength 0.10
- Koji Shindo · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.